Alkem Laboratories

Manufacturing

New Diovan generic approved as FDA attacks valsartan shortage

The FDA has approved a new generic of Diovan from India's Alkem to help relieve a shortage of the ubiquitous high blood pressure treatment.
Eric Palmer Mar 13, 2019 10:16am

India's Alkem says the FDA approved upgrade for cited API plant

Apr 4, 2017 9:13am

FDA smacks third Alkem plant with Form 483

Mar 14, 2017 9:31am

India's Alkem faces new FDA concerns

Sep 30, 2016 11:51am

Alkem in EMA data fraud probe

Apr 17, 2016 7:02pm